New York Magazine Bemoans Trump’s ‘Dangerous’ Attacks

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
New York Magazine Bemoans Trump’s ‘Dangerous’ Attacks on Biased Media

As this election year gears down toward a frenzied conclusion, one of the constants of modern American politics, Republican demonization of the mainstream news media as “biased,” is reaching a new level of savagery at the hands of Donald Trump.

Commenting on the tone of Trump rallies this week, Politico’s Ben Schreckinger was clearly shaken by the anti-media hate fever:

As the Republican nominee has resorted to more extreme denunciations of the press in recent days, his supporters have followed suit. Chants of “CNN sucks” have become commonplace at Trump’s rallies this week and members of the traveling press were called “whores” and “press-titutes” as they filed out of a Thursday afternoon rally in West Palm Beach. Minutes before, Trump had accused reporters of participating in a vast globalist conspiracy against his campaign and American workers.

No, it’s not just rootless cosmopolitans and international bankers who are in league with Crooked Hillary to destroy the U.S. economy and keep the white man down. It’s also the media folk who made the second presidential debate a “one-on-three” unequal battle, as Trump self-pityingly (or more likely, cynically) argued in accosting the two moderators.

Crowds that once booed and shouted at the press mainly at Trump’s prompting — when he would decry them as “dishonest” and “scum” or demand that television cameras pan his crowds — have now begun spontaneously targeting the press on their own, at a scale not yet seen in this campaign, or any in memory on American soil.

Now Ben Schreckinger is pretty young, and so cannot remember George Wallace’s presidential campaigns, wherein it was standard procedure for the candidate to point out liberal Yankee reporters to his angry supporters at campaign events. But Wallace seemed to be toying with mainstream media figures rather than actively threatening them, and he was never a major-party presidential nominee, either.

It is also hard to think of a precedent for a presidential candidate who has made the game of “beat the press” (to borrow the name of Dean Baker’s blog, which aims a critical but judicious eye at economics reporting) so integral and multifaceted a part of his campaign. The immediate motive for the latest bout of Trumpian media-bashing is to counter the drumbeat of new allegations about the mogul’s crude and possibly illegal sexual behavior and his habit of saying creepy things about women. What the media ought to be covering, say Trump and his surrogates, is the WikiLeaks disclosures of Clinton campaign emails. But the broader trend in the Trump camp’s rhetoric is to go “full Breitbart”: to regard all “Establishment” politicians and media outlets, even those normally thought of as conservatives, as part of a conspiracy to defend the status quo. For readers who have risked singed hair and shocked sensibilities by reading the website recently run by Trump’s campaign chairman Stephen Bannon, Breitbart.com turns the volume of media-hatred right up to 11.

Arguably these developments are mainly of interest to journalists who with good reason fear that their ability to do their jobs — and perhaps even their liberty — could be at risk if Trump somehow wins. But there is growing danger to the integrity of the election itself, and to civic peace on and after November 8.

The same allegedly lying and conspiring media who are tormenting poor Trump are the people who will report on and interpret the elections toward which we are barreling. Trump has already conspicuously warned that the election is “rigged” or will be “stolen” and is stirring up his supporters to police voting sites for signs of chicanery. To be sure, “voter fraud” is mostly imaginary, but it’s an emotionally powerful symbol of white fears that minority folk will be herded by their government-benefit paymasters to the polls to vote themselves more welfare (and/or less immigration enforcement).

Let’s say the Breitbartians gin up some real Election Day hysteria about the “rigged” or “stolen” election, and it merges with rumors or even reports of election-machinery hacking — say, from somewhere in the vicinity of Russia. You have all the ingredients for a disputed election, and perhaps real and widespread violence. After all, if the people telling us what’s happening are part of a conspiracy to change what’s happening, what other recourse does the frightened patriot have?

In the first presidential debate Trump famously promised not only to accept defeat if it comes to pass, but to “support” a President-elect Hillary Clinton if there is one. But he began backing away from that pledge almost immediately, and it is getting hard to imagine him on November 9 telling his supporters to stop demanding Clinton’s incarceration and begin treating her as a legitimate chief executive. Besides, it was one of those lying debate moderators who ambushed Trump with the question about accepting Clinton, and you can’t trust any of them, can you?
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Health Hit by FTC Claims and Class Action

Updated Category News Views 1

Hims Faces Harsh Lessons With FTC Lawsuit There's trouble brewing in the world of telehealth, and Hims & Hers Health (NYSE: HIMS) is right at the eye of the storm. They've gone from a darling of digital health to a pariah faster than you can say 'data breach.' On July 29, 2026, they took a hit so hard you’d think the company stepped into the ring with a heavyweight...

Continue Reading
U.S. Court Ruling Opens Market for Cocrystal's CrysQnol™

Updated Category News Views 1

Legal Drama Clears Market Path Well, folks, here’s a win from the trenches for Cocrystal Tech that can shake up the nutraceutical market. Kaneka's grip on the patent for their ubiquinol concoctions just got busted by the U.S. District Court. They ruled that Kaneka's claims lacked utility and enablement, essentially saying they were pitching an untested hypothesis as an...

Continue Reading
Regeneron Faces Class Action Over Tumultuous Trial Results

Updated Category News Views 1

Regeneron's Meltdown: A Bitter Pill for Investors Let’s dive headlong into the mess Regeneron Pharmaceuticals (NASDAQ:REGN) finds itself in—a classic nightmare scenario for investors. News broke like an old valve bursting, and suddenly, the market's love for Regeneron ran ice-cold. Who's to blame this time? Well, you might want to point a finger at the failed Phase 3...

Continue Reading
Insurance 101: Know Your Limits and Deductibles

Updated Category News Views 4

It might not exactly be cocktail party fodder, but boy, skipping on understanding your homeowners insurance is a shortcut straight to financial hell. You’re living in St. Albans, WV, in a home that’s probably your biggest investment. Let’s talk about this before you find yourself in a mess you should've seen coming. Why Coverage Limits Matter a Whole Lot Listen up,...

Continue Reading
vivo and UNESCO Unite Youth for Nature Stories

Updated Category News Views 4

Young Creators Explore Nature Through a New Lens Pontremoli, Italy just became the backdrop for an extraordinary gathering of young visionaries. From August 31 to September 5, UNESCO’s Man and the Biosphere (MAB) Programme and vivo wrapped their 2026 Capture the Future initiative in the lush landscapes of the Appennino Tosco Emiliano Biosphere Reserve. It’s one thing...

Continue Reading
Fosun Pharma Hits the Buyback Button: What's Next?

Updated Category News Views 4

Fosun Pharma's Bold Move Well, if this isn't Fosun Pharma making some noise! Announcing an H-share repurchase plan worth up to HK$1 billion is like setting off fireworks amidst any investor's evening. They're hollering to the market, 'We see value, and we're doubling down on it.' Crunching the Numbers In the first half of 2026, Fosun Pharma's numbers weren't just a flash...

Continue Reading
Nurminen Logistics Doubles Sweden–Italy Rail Capacity

Updated Category News Views 4

Nurminen Logistics Betting Big on Rail Expansion Feeling the pulse of the logistics world is much like trying to catch lightning in a bottle, but Nurminen Logistics seems to have found its rhythm. They're ramping up their services between Sweden and Italy, leveraging rail to push the envelope. Come October, they're doubling down from one to two weekly departures, giving...

Continue Reading
ACG Moves to Acquire Ke?kek for $7.85M Gold Venture

Updated Category News Views 3

Here's the scoop: ACG Metals Limited is stepping up the game, attempting to snag the Ke?kek gold project in a deal worth up to $7.85 million. This move, they say, is all about bolstering the future of their gold production—and squeezing every ounce out of that Gediktepe facility in Türkiye. It's like squeezing juice from a lemon that's still got a bit of life left....

Continue Reading
Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 3

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
Consumer365 Highlights Happy Head's Personalized Hair Solutions

Updated Category News Views 1

Tailored Hair Loss Solutions by Happy Head Imagine trying to fit a square peg in a round hole. That's what one-size-fits-all approaches often feel like in the world of hair loss treatments. Happy Head, recognized by Consumer365, takes that notion and turns it on its head, offering personalized minoxidil formulations for women. The key word here is personalized. More Than...

Continue Reading

Top 5 Most Recently Viewed Articles

Avocados From Mexico Celebrates Certification as Great Employer

Updated Category News Views 51

Avocados From Mexico Achieves Prestigious Great Place To Work Certification Avocados From Mexico is widely recognized not just as the top-selling avocado brand in the United States, but also as a Certified Great Place To Work. This esteemed certification reflects the positive feedback from current employees regarding their experiences within the company. An impressive 97%...

Continue Reading
Etex Shows Stability and Growth Amid Market Challenges in 2025

Updated Category News Views 370

Etex's Strong Half-Year Financial Performance Etex has demonstrated significant resilience in its half-year financial performance, navigating a construction environment that remains largely unpredictable. This strength is highlighted by a steady sales volume and healthy margins, confirming the company's expectations for the period. Overview of Financial Results The...

Continue Reading
First Horizon Bank Becomes Official Partner of NC Courage

Updated Category News Views 111

First Horizon Bank Officially Partners with NC Courage In an exciting development for women's sports, First Horizon Bank (NYSE: FHN) has been named the Official Bank of the North Carolina Courage, marking the start of a multiyear partnership aimed at bolstering community initiatives. This collaboration is an incredible opportunity to enhance support for women's athletics...

Continue Reading
Curis Announces Upcoming Presentations on Emavusertib Research

Updated Category News Views 193

Curis Prepares for Major Presentations at SNO Meeting LEXINGTON, Mass. — Curis, Inc. (NASDAQ: CRIS) is excited to share that the company will participate in the prestigious 30th Annual Meeting of the Society for Neuro-Oncology (SNO). This event is taking place soon, and Curis intends to showcase significant clinical data regarding emavusertib (CA-4948), a promising...

Continue Reading
Novel Approach to PTSD Treatment Unveiled in Recent Study

Updated Category News Views 391

Recent Advancements in PTSD Research Otsuka Pharmaceutical Development & Commercialization, Inc. and Lundbeck LLC have made headlines with the publication of a Phase 3 trial of brexpiprazole combined with sertraline for treating Post-Traumatic Stress Disorder (PTSD) in adults. The findings, appearing in JAMA Psychiatry, indicate a significant improvement in PTSD symptoms...

Continue Reading